We have expanded our collection of missense alleles of
unc-54 that suppress
unc-22 induced twitching to a total of 17
unc-22 suppressors. These mutations can be split into two classes, an
s74-like class with
t4 members (see Cell 29, 773-781) and a new class with 3 members,
st130,
st132 and
st148. This new class of mutations also act as dominant suppressors of
unc-22(
s12) and
unc-22(
st137::
tc1), and a worm heterozygous for any of these mutations moves like N2 and has normal muscle structure. However, an animal homozygous for
st130,
st132 or
st148 is slow, does not lay eggs, and the muscle cells exhibit significant A-band disorganization. It is this last trait that distinguishes this new class of mutation from mutations of the
s74- like class which affect movement but have little, or no affect on A- band organization. We have carried out an extensive series of reversion experiments using
s74,
s95,
st130 and
st132 to see if there are either inter- or intragenic sites that interact with these mutations. The results are summarized below. [See Figure 1] Only
st150, an
s95 revertant, proved to be an extragenic suppressor and it is probably a
sup-3 allele. The other revertants are the result of intragenic events. The frequency at which intragenic revertants of
st132 occur as compared to
s95 (a member of the
s74-like class) further suggests that
st132 defines a new class of mutation in
unc-54. The
st130 revertant and 2 of the
st132 revertants are partial revertants while the other
st132 revertants are full revertants to wild type. This latter set has been divided into 2 groups - of 13 tested mutations, 9 are dosage dependent, ie
st132/st132,
st132 m/st132 +, and
st132 m/st132 m have 3 discernable movement phenotypes, and 5 are dosage independent, ie, restoration of wild type movement is fully dominant. The dosage response and the high reversion frequency of
st132 indicates that compensatory second-site mutations in
unc-54 can occur. The
s95 intragenic mutations are full revertants and 5 of these were analyzed at the DNA level. The
s95 mutation is at position 2340 in the nucleotide sequence and changes CCA (gly) to ACA (arg) (J.M.B. 183, 543-551). Fortuitously
s95 disrupts a HpaII site (CCCC to CCAC). Of the 5 intragenic revertants examined by Southern analysis, only one restores the HpaII site. After cloning and sequencing the other 4 revertants we were surprised to find that all 4 have the same nucleotide change at position 2342 thus altering ACA (arg) to ACT (ser) . Our inability to find compensatory mutations in another part of unc- 54 suggests that
s95 may disrupt interactions with a molecule other than myosin. The proximity of
s95 to the putative ATP binding site ( EMB0 1, 945-951; P.N.A.S. 80, 4253-4257) makes ATP a likely candidate.